Researchers at the University of Arizona have found a promising new biomarker that may help with early detection of stomach cancer.
The biomarker can be detected through a simple blood test, and appears in patients before the disease develops, saving time and lowering treatment costs. Currently, stomach cancer diagnosis requires endoscopic collection of tissue through a biopsy procedure, and then analysis by pathology. U of A researchers say the new biomarker may also improve patient response to therapy.
